arBtrage CAPITALIZING MARKETS checking… Sign in

Avalo Therapeutics, Inc.

AVTX Health Care Biotechnology: Pharmaceutical Preparations
$13.10
▼ -3.8% Today
as of Jun 7, 07:09 ET
Last 30 days +1.87% Apr 28 → Jun 05
$12.06 $14.96 $17.87 $20.77 $23.67 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$13.62
High
$13.76
Low
$12.89
Volume
$2M
Avg Vol
$636,378
Mkt Cap
$848M
P/E (TTM)
Beta
52w High
$24.27
52w Low
$4.06
Div Yield
Shares Out
$25M

Overview

52-week range
$4.06
$24
45% of range
Avg surprise (last 2)
-7.4%
Avg reaction (last 2)
-1.0%
0% positive
Latest IV / EM
163%
EM ±22.5% · $13 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-141.14$-105.60$-70.07$-34.53$1.00 Actual $-140.73Actual $-26.83Actual $-141.14Actual $-14.07Actual $-2.83Actual $-1.25Est $-1.07Actual $-1.92Actual $-2.19Actual $-0.98Est $1.00 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-31M$3M$36M$70M$103M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.98 $1.00 +2.0% +21.6% -0.5% earnings
Tue Sep 30, 2025Sep 2025 $-2.19 financials
Mon Jun 30, 2025Jun 2025 $-1.92 financials
Mon May 12, 2025Mar/2025 $-1.25 $-1.07 -16.8% -1.5% earnings
Mon Sep 30, 2024Sep 2024 $-2.83 financials
Sun Jun 30, 2024Jun 2024 $-14.07 financials
Sun Mar 31, 2024Mar 2024 $-141.14 financials
Sat Sep 30, 2023Sep 2023 $-26.83 financials
Fri Jun 30, 2023Jun 2023 $-140.73 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$0$-714,000$343,000
Gross profit
Operating income$-21M$-19M$-19M$-15M$-13M$-10M
Net income$-20M$-31M$-21M$-13M$23M$98M
EPS (diluted)$-0.98$-2.19$-1.92$-1.25$-2.83$-14.07

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$25M$16M$27M$42M$125M$135M$82M$93M
Inventory
Total current assets$89M$105M$114M$115M$127M$139M$86M$96M
Total assets$100M$116M$125M$127M$139M$151M$98M$108M
Long-term debt
Total liabilities$32M$33M$34M$22M$16M$18M$76M$110M
Total equity$68M$83M$92M$105M$123M$133M$21M$-14M

Implied volatility — last 90 days

157%160%162%165%167% Jun 07 — IV 163% · EM ±22.5%

Sector peers